Immatics IMTX
NASDAQ IMTX
$7.50 -0.19 (-2.47%)
As of: Oct 22, 2026 · 10:56 AM EDT

Immatics (IMTX) Non-Current Deffered Revenue (2019 - 2026)

Updated

Analysis

Immatics (IMTX) Non-Current Deffered Revenue (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn -
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn -
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn -
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn -
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn -
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -
10 Immatics 920.06 Mn -1.11 Bn - 15.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.57 Mn
Mar 31, 2026 18.20 Mn
Dec 31, 2025 21.78 Mn
Sep 30, 2025 26.33 Mn
Jun 30, 2025 32.32 Mn
Mar 31, 2025 31.57 Mn
Dec 31, 2024 35.55 Mn
Sep 30, 2024 58.75 Mn
Jun 30, 2024 80.63 Mn
Mar 31, 2024 98.62 Mn
Dec 31, 2023 127.87 Mn
Sep 30, 2023 57.95 Mn
Jun 30, 2023 58.21 Mn
Mar 31, 2023 71.18 Mn
Dec 31, 2022 80.76 Mn
Sep 30, 2022 101.46 Mn
Jun 30, 2022 120.47 Mn
Mar 31, 2022 75.66 Mn
Dec 31, 2021 54.61 Mn
Sep 30, 2021 60.60 Mn
API Access

Immatics Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IMTX&period=max&api_key=YOUR_API_KEY